LPC
ABBV icon

Loeb Partners Corp’s AbbVie ABBV Stock Holding History

Loeb Partners Corp’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-650
Closed -$52K – 3
2019
Q1 		$52K Sell
650
-2,120
-77% -$173K 1.07% 24
2018
Q4 		$254K Sell
2,770
-4,800
-63% -$422K 0.12% 120
2018
Q3 		$716K Sell
7,570
-19,700
-72% -$1.87M 0.26% 77
2018
Q2 		$2.53M Buy
27,270
+14,790
+119% +$1.44M 0.64% 49
2018
Q1 		$1.18M Sell
12,480
-2,950
-19% -$324K 0.51% 52
2017
Q4 		$1.49M Hold
15,430
– – 0.44% 60
2017
Q3 		$1.37M Sell
15,430
-200
-1% -$15.2K 0.42% 59
2017
Q2 		$1.13M Sell
15,630
-250
-2% -$16.8K 0.33% 69
2017
Q1 		$1.03M Buy
15,880
+400
+3% +$25.1K 0.31% 77
2016
Q4 		$969K Buy
+15,480
New +$945K 0.33% 75
2016
Q3 		– Sell
-5,480
Closed -$339K – 153
2016
Q2 		$339K Buy
+5,480
New +$334K 0.11% 120
2015
Q3 		– Sell
-13,055
Closed -$877K – 165
2015
Q2 		$877K Sell
13,055
-7,000
-35% -$457K 0.25% 84
2015
Q1 		$1.17M Sell
20,055
-17,850
-47% -$1.08M 0.34% 78
2014
Q4 		$2.48M Buy
37,905
+18,900
+99% +$1.19M 0.74% 41
2014
Q3 		$1.1M Hold
19,005
– – 0.36% 75
2014
Q2 		$1.07M Sell
19,005
-69,150
-78% -$3.63M 0.33% 80
2014
Q1 		$4.53M Hold
88,155
– – 1.52% 17
2013
Q4 		$4.66M Buy
88,155
+42,500
+93% +$2.09M 1.49% 17
2013
Q3 		$2.04M Hold
45,655
– – 0.69% 40
2013
Q2 		$1.89M Buy
+45,655
New +$2M 0.69% 42

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Loeb Partners Corp's ABBV Position: Q2 2019 in Review

Loeb Partners Corp sold out of AbbVie (ABBV) in Q2 2019, closing a stake of 650 shares — an estimated $52K sold.

Loeb Partners Corp first reported a position in ABBV in Q2 2013 and held it in 20 quarters. The position peaked at $4.66M in Q4 2013. 2,020 funds tracked by Wall St. Rank hold ABBV as of Q2 2019.

  • Loeb Partners Corp reported no remaining AbbVie position as of Q2 2019 after selling out during the quarter.
  • Loeb Partners Corp sold 650 AbbVie shares in Q2 2019, an estimated $52K.
  • Loeb Partners Corp first reported a position in AbbVie in Q2 2013 and held it in 20 quarters.
  • Loeb Partners Corp's AbbVie position peaked at $4.66M in Q4 2013.
  • 2,020 funds tracked by Wall St. Rank held AbbVie as of Q2 2019.

Based on Loeb Partners Corp's 13F filing for Q2 2019.